Skip to main content

Private Advisor Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1567755 MORRISTOWN, NJ

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$5,528,512
-$1,444,865 QoQ
Shares Held
43,759
-12.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#558
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2023
CallValue
$28,252
CallShares
37,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
43,759 $5,528,512

All Filings in GILD

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,528,512 43,759
2026-03-31 $6,973,377 50,035
2025-12-31 $5,649,108 46,025
2025-09-30 $4,948,713 44,583
2025-06-30 $4,713,527 42,514
2025-03-31 $4,288,713 38,275
2024-12-31 $3,203,576 34,682
2024-09-30 $3,156,240 37,646
2024-06-30 $2,980,418 43,440
2024-03-31 $3,259,258 44,495
2023-12-31 $4,415,855 54,510
2023-09-30 $28,252 37,700
2023-09-30 $3,970,695 52,985
2023-06-30 $4,334,108 56,236
2023-03-31 $4,510,664 54,365
2022-12-31 $4,904,438 57,128
2022-09-30 $3,298,625 53,471
2022-06-30 $4,969,214 80,395
2022-03-31 $4,602,678 77,421
2021-12-31 $7,088,696 97,627
2021-09-30 $9,760,629 139,737
2021-06-30 $5,703,880 82,833
2021-03-31 $5,220,100 80,769
2020-12-31 $4,116,069 70,650
2020-09-30 $3,569,792 56,493
2020-06-30 $4,906,617 63,772
2020-03-31 $4,272,160 57,145